Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Evaluating Vinorelbine Plus Capecitabine in the Treatment of Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy

NCT04307147 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT04307147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04307147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Evaluating Vinorelbine Plus Capecitabine in the Treatment of Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy
Lead sponsor
Fudan University
Phase
Phase 3
Overall status
Unknown status
Start date
July 3, 2018
Completion date
September 1, 2021
Enrollment
316 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer